Ergoteles’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,286	Closed	-$217K	–	1722
2022 Q3	$217K	Buy	+1,286	New	+$217K	0.01%	1139
2021 Q2	–	Sell	-544	Closed	-$220K	–	1615
2021 Q1	$220K	Buy	+544	New	+$220K	0.01%	634